Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Bjarne Linde, Nørgaard"'
Autor:
Jakob Nyvad, Kent Lodberg Christensen, Gratien Andersen, Mark Reinhard, Bjarne Linde Nørgaard, Jonna Skov Madsen, Sebastian Nielsen, Martin Bjergskov Thomsen, Jesper Møller Jensen, Christian Daugaard Peters, Niels Henrik Buus
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Patients with chronic kidney disease (CKD) are susceptible to vascular calcification and vitamin K deficiency. Matrix gla protein (MGP) is a potent inhibitor of calcification requiring vitamin K for activation. Inactive MGP, i.e.
Externí odkaz:
https://doaj.org/article/1d144fd7b74f4d0ca3196ff22a8840c6
Autor:
Gregory Wood, Alexandra Uglebjerg Pedersen, Karl P. Kunze, Radhouene Neji, Reza Hajhosseiny, Jens Wetzl, Seung Su Yoon, Michaela Schmidt, Bjarne Linde Nørgaard, Claudia Prieto, René M. Botnar, Won Yong Kim
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 25, Iss 1, Pp 1-10 (2023)
Abstract Background Coronary magnetic resonance angiography (coronary MRA) is increasingly being considered as a clinically viable method to investigate coronary artery disease (CAD). Accurate determination of the trigger delay to place the acquisiti
Externí odkaz:
https://doaj.org/article/dc3b9fe1eed1404ab126f758860c23ff
Autor:
Gregory Wood, Reza Hajhosseiny, Alexandra Uglebjerg Pedersen, Simon Littlewood, Tina Juul Hansen, Radhouene Neji, Karl P. Kunze, Jens Wetzl, Bjarne Linde Nørgaard, Jesper Møller Jensen, Michael Maeng, Per Lav Madsen, Niels Vejlstrup, Claudia Prieto, René M. Botnar, Won Yong Kim
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 26, Iss 2, Pp 101097- (2024)
ABSTRACT: Background: Coronary computed tomography angiography (CCTA) is recommended as the first-line diagnostic imaging modality in low-to-intermediate-risk individuals suspected of stable coronary artery disease (CAD). However, CCTA exposes patien
Externí odkaz:
https://doaj.org/article/ccdd93f9ed2d4284a5f2d2ab84fa39fc
Autor:
Martin Bødtker Mortensen, Omar Dzaye, Hans Erik Bøtker, Jesper Møller Jensen, Michael Maeng, Jacob Fog Bentzon, Helle Kanstrup, Henrik Toft Sørensen, Jonathon Leipsic, Ron Blankstein, Khurram Nasir, Michael J. Blaha, Bjarne Linde Nørgaard
Publikováno v:
Mortensen, M B, Dzaye, O, Bøtker, H E, Jensen, J M, Maeng, M, Bentzen, J F, Kanstrup, H, Sørensen, H T, Leipsic, J, Blankstein, R, Nasir, K, Blaha, M J & Nørgaard, B L 2023, ' Low-Density Lipoprotein Cholesterol Is Predominantly Associated With Atherosclerotic Cardiovascular Disease Events in Patients With Evidence of Coronary Atherosclerosis : The Western Denmark Heart Registry ', Circulation, vol. 147, no. 14, pp. 1053-1063 . https://doi.org/10.1161/CIRCULATIONAHA.122.061010
Background: Low-density lipoprotein cholesterol (LDL-C) is an important causal risk factor for atherosclerotic cardiovascular disease (ASCVD). However, a sizable proportion of middle-aged individuals with elevated LDL-C level have not developed coron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f00fc5c36407f50004fae2d3bb1592fe
https://doi.org/10.1161/circulationaha.122.061010
https://doi.org/10.1161/circulationaha.122.061010
Autor:
Mads Brix Kronborg, Maria Hee Jung Park Frausing, Jesper Hastrup Svendsen, Jens Brock Johansen, Sam Riahi, Jens Haarbo, Steen Hvitfeldt Poulsen, Hans Eiskjær, Lars Køber, Kristian Øvrehus, Anders Munck Sommer, Morten Schou, Bjarne Linde Nørgaard, Niels Risum, Mikael Kjær Poulsen, Peter Søgaard, Niels Sandgaard, Klaus F. Kofoed, Thomas Fritz Hansen, Claus Graff, Susanne S Pedersen, Regitze Gyldenholm Skals, Jens Cosedis Nielsen
Publikováno v:
Kronborg, M B, Frausing, M H J P, Svendsen, J H, Johansen, J B, Riahi, S, Haarbo, J, Poulsen, S H, Eiskjær, H, Køber, L, Øvrehus, K, Sommer, A M, Schou, M, Nørgaard, B L, Risum, N, Poulsen, M K, Søgaard, P, Sandgaard, N, Kofoed, K F, Hansen, T F, Graff, C, Pedersen, S S, Skals, R G & Nielsen, J C 2023, ' Does Targeted Positioning of the Left Ventricular Pacing Lead Towards the Latest Local Electrical Activation in Cardiac Resynchronization Therapy Reduce the Incidence of Death or Hospitalization for Heart Failure? ', American Heart Journal, vol. 263, pp. 112-122 . https://doi.org/10.1016/j.ahj.2023.05.011
Kronborg, M B, Frausing, M H J P, Svendsen, J H, Johansen, J B, Riahi, S, Haarbo, J, Poulsen, S H, Eiskjær, H, Køber, L, Øvrehus, K, Sommer, A M, Schou, M, Nørgaard, B L, Risum, N, Poulsen, M K, Søgaard, P, Sandgaard, N, Kofoed, K F, Hansen, T F, Graff, C, Pedersen, S S, Skals, R G & Nielsen, J C 2023, ' Does Targeted Positioning of the Left Ventricular Pacing Lead Towards the Latest Local Electrical Activation in Cardiac Resynchronization Therapy Reduce the Incidence of Death or Hospitalization for Heart Failure? ', American Heart Journal . https://doi.org/10.1016/j.ahj.2023.05.011
Kronborg, M B, Frausing, M H J P, Svendsen, J H, Johansen, J B, Riahi, S, Haarbo, J, Poulsen, S H, Eiskjær, H, Køber, L, Øvrehus, K, Sommer, A M, Schou, M, Nørgaard, B L, Risum, N, Poulsen, M K, Søgaard, P, Sandgaard, N, Kofoed, K F, Hansen, T F, Graff, C, Pedersen, S S, Skals, R G & Nielsen, J C 2023, ' Does Targeted Positioning of the Left Ventricular Pacing Lead Towards the Latest Local Electrical Activation in Cardiac Resynchronization Therapy Reduce the Incidence of Death or Hospitalization for Heart Failure? ', American Heart Journal . https://doi.org/10.1016/j.ahj.2023.05.011
BackgroundCardiac resynchronization therapy (CRT) improves symptoms, health-related quality of life and long-term survival in patients with systolic heart failure (HF) and shortens QRS duration. However, up to one third of patients attain no measurab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99cf6502a8cb086622c42d8a2fa3d069
https://pure.au.dk/portal/da/publications/does-targeted-positioning-of-the-left-ventricular-pacing-lead-towards-the-latest-local-electrical-activation-in-cardiac-resynchronization-therapy-reduce-the-incidence-of-death-or-hospitalization-for-heart-failure(16e6f135-ab26-442e-868f-68e02be687b4).html
https://pure.au.dk/portal/da/publications/does-targeted-positioning-of-the-left-ventricular-pacing-lead-towards-the-latest-local-electrical-activation-in-cardiac-resynchronization-therapy-reduce-the-incidence-of-death-or-hospitalization-for-heart-failure(16e6f135-ab26-442e-868f-68e02be687b4).html
Autor:
Sophie E. van Rosendael, Alexander R. van Rosendael, Jurrien H. Kuneman, Manesh R. Patel, Bjarne Linde Nørgaard, Timothy A. Fairbairn, Koen Nieman, Takashi Akasaka, Daniel S. Berman, Lynne M. Hurwitz Koweek, Gianluca Pontone, Tomohiro Kawasaki, Niels Peter Rønnow Sand, Jesper M. Jensen, Tetsuya Amano, Michael Poon, Kristian A. Øvrehus, Jeroen Sonck, Mark G. Rabbat, Campbell Rogers, Hitoshi Matsuo, Jonathon A. Leipsic, Nina Ajmone Marsan, J. Wouter Jukema, Jeroen J. Bax, Antti Saraste, Juhani Knuuti
Publikováno v:
van Rosendael, S E, van Rosendael, A R, Kuneman, J H, Patel, M R, Nørgaard, B L, Fairbairn, T A, Nieman, K, Akasaka, T, Berman, D S, Koweek, L M H, Pontone, G, Kawasaki, T, Sand, N P R, Jensen, J M, Amano, T, Poon, M, Øvrehus, K A, Sonck, J, Rabbat, M G, Rogers, C, Matsuo, H, Leipsic, J A, Marsan, N A, Jukema, J W, Bax, J J, Saraste, A & Knuuti, J 2023, ' Coronary Volume to Left Ventricular Mass Ratio in Patients With Hypertension ', The American Journal of Cardiology, vol. 199, pp. 100-109 . https://doi.org/10.1016/j.amjcard.2023.04.025
The coronary vascular volume to left ventricular mass (V/M) ratio assessed by coronary computed tomography angiography (CCTA) is a promising new parameter to investigate the relation of coronary vasculature to the myocardium supplied. It is hypothesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a741dad7bb72452ac03ecd5cde53543b
https://pure.au.dk/portal/da/publications/coronary-volume-to-left-ventricular-mass-ratio-in-patients-with-hypertension(26e75f0b-8baa-4fea-a1f4-3c4a436d3d5d).html
https://pure.au.dk/portal/da/publications/coronary-volume-to-left-ventricular-mass-ratio-in-patients-with-hypertension(26e75f0b-8baa-4fea-a1f4-3c4a436d3d5d).html
Autor:
Kasper Korsholm, Anders Kramer, Asger Andersen, Jacqueline Saw, Bjarne Linde Nørgaard, Jesper Møller Jensen, Jens Erik Nielsen-Kudsk
Publikováno v:
Korsholm, K, Kramer, A, Andersen, A, Saw, J, Nørgaard, B L, Jensen, J M & Nielsen-Kudsk, J E 2023, ' Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device ', Journal of Interventional Cardiac Electrophysiology, vol. 66, no. 2, pp. 391-401 . https://doi.org/10.1007/s10840-022-01336-4
Background The left atrial appendage (LAA) sealing properties of the Amplatzer Amulet and Watchman FLX devices were compared using cardiac computed tomography (CT) follow-up. Methods Single-center cohort study of patients undergoing LAAO between 2017
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e1b64b74a0c23ce34ea284e2848aa19
https://doi.org/10.1007/s10840-022-01336-4
https://doi.org/10.1007/s10840-022-01336-4
Autor:
Thomas Jensen, Pernille G Thrane, Kevin K W Olesen, Morten Würtz, Martin Bødtker Mortensen, Christine Gyldenkerne, Troels Thim, Bjarne Linde Nørgaard, Jesper Møller Jensen, Steen Dalby Kristensen, Jens C Nielsen, John W Eikelboom, Michael Maeng
Publikováno v:
Jensen, T, Thrane, P G, Olesen, K K W, Würtz, M, Mortensen, M B, Gyldenkerne, C, Thim, T, Nørgaard, B L, Jensen, J M, Kristensen, S D, Nielsen, J C, Eikelboom, J W & Maeng, M 2023, ' Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation ', European heart journal. Cardiovascular pharmacotherapy, vol. 9, no. 3, 208-219 . https://doi.org/10.1093/ehjcvp/pvac058
Aims Beyond 1 year after percutaneous coronary intervention (PCI), guidelines recommend anticoagulant monotherapy in patients with atrial fibrillation (AF) rather than dual therapy with an anticoagulant and an antiplatelet drug. The risks and benefit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7add3fd87c25fefd581498b0774066c2
https://pure.au.dk/portal/da/publications/antithrombotic-treatment-beyond-1-year-after-percutaneous-coronary-intervention-in-patients-with-atrial-fibrillation(9eb5a09e-3167-42a4-abfa-095dd6fb12e6).html
https://pure.au.dk/portal/da/publications/antithrombotic-treatment-beyond-1-year-after-percutaneous-coronary-intervention-in-patients-with-atrial-fibrillation(9eb5a09e-3167-42a4-abfa-095dd6fb12e6).html
Autor:
Anders Dahl Kramer, Kasper Korsholm, Jesper Møller Jensen, Bjarne Linde Nørgaard, Srikara Peelukhana, Thomas Herbst, Rodney Horton, Saibal Kar, Jacqueline Saw, Mohamad Alkhouli, Jens Erik Nielsen-Kudsk
Publikováno v:
Kramer, A D, Korsholm, K, Jensen, J M, Nørgaard, B L, Peelukhana, S, Herbst, T, Horton, R, Kar, S, Saw, J, Alkhouli, M & Nielsen-Kudsk, J E 2023, ' Cardiac computed tomography following Watchman FLX implantation : device-related thrombus or device healing? ', European Heart Journal Cardiovascular Imaging, vol. 24, no. 2, pp. 250-259 . https://doi.org/10.1093/ehjci/jeac222
Aims Cardiac computed tomography (CT) is increasingly utilized during follow-up after left atrial appendage closure (LAAC). Hypoattenuated thickening (HAT) is a common finding and might represent either benign device healing or device-related thrombo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dfcbf1b1b06718c0659e13d41f77043
https://pure.au.dk/portal/da/publications/cardiac-computed-tomography-following-watchman-flx-implantation(eec92c20-ca73-4cfc-bc62-b014d18937a6).html
https://pure.au.dk/portal/da/publications/cardiac-computed-tomography-following-watchman-flx-implantation(eec92c20-ca73-4cfc-bc62-b014d18937a6).html
Autor:
Thomas, Jensen, Pernille Gro, Thrane, Kevin Kris Warnakula, Olesen, Morten, Würtz, Martin Bødtker, Mortensen, Christine, Gyldenkerne, Troels, Thim, Bjarne Linde, Nørgaard, Jesper Møller, Jensen, Steen Dalby, Kristensen, Jens Cosedis, Nielsen, John W, Eikelboom, Michael, Maeng
Publikováno v:
European heart journal. Cardiovascular pharmacotherapy.
Beyond 1 year after percutaneous coronary intervention (PCI), guidelines recommend anticoagulant monotherapy in patients with atrial fibrillation (AF) rather than dual therapy with an anticoagulant and an antiplatelet drug. The risks and benefits of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57a563c9df0d9519988fe831bbbda6e8
https://pubmed.ncbi.nlm.nih.gov/36269306
https://pubmed.ncbi.nlm.nih.gov/36269306